Rani Therapeutics Holdings Stock Overlap Studies Triangular Moving Average

RANI Stock  USD 2.08  0.04  1.96%   
Rani Therapeutics overlap studies tool provides the execution environment for running the Triangular Moving Average study and other technical functions against Rani Therapeutics. Rani Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triangular Moving Average study function is designed to identify and follow existing trends. Rani Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was two with a total number of output elements of fifty-nine. The Triangular Moving Average shows Rani Therapeutics double smoothed mean price over a specified number of previous prices (i.e., averaged twice).

Rani Therapeutics Technical Analysis Modules

Most technical analysis of Rani Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Rani from various momentum indicators to cycle indicators. When you analyze Rani charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Rani Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rani Therapeutics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Rani Therapeutics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Rani Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Rani Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Rani Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Rani Therapeutics, we also check how macroeconomic factors affect Rani Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Graham Number3.893.69
Receivables Turnover0.310.29
Hype
Prediction
LowEstimatedHigh
0.102.0612.05
Details
Intrinsic
Valuation
LowRealHigh
0.357.0917.08
Details
Naive
Forecast
LowNextHigh
0.041.9411.93
Details
8 Analysts
Consensus
LowTargetHigh
20.2522.2524.70
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Gambling Idea
Gambling
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Rani Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rani Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rani Therapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rani Therapeutics Holdings Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rani Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rani Therapeutics. If investors know Rani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rani Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.05)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.57)
Return On Equity
(2.25)
The market value of Rani Therapeutics is measured differently than its book value, which is the value of Rani that is recorded on the company's balance sheet. Investors also form their own opinion of Rani Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Rani Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rani Therapeutics' market value can be influenced by many factors that don't directly affect Rani Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rani Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rani Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rani Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.